Skip to main
TRLV

TRLV Stock Forecast & Price Target

TRLV Analyst Ratings

Based on 1 analyst ratings
Buy
Strong Buy 0%
Buy 100%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Trulieve Cannabis is a leading vertically integrated U.S. cannabis company with established operations in Florida, Georgia, Pennsylvania, and West Virginia. The company's strategic positioning in key markets, including its ability to capitalize on regulatory changes in states like Georgia and Texas, provides it with meaningful organic growth opportunities. Trulieve's diversified product portfolio and focus on customer engagement through initiatives like Project Hyper make it well-positioned to capture a significant share of the expanding U.S. cannabis market, which is projected to reach $43 billion by 2030.

Bears say

Trulieve Cannabis is facing negative headwinds due to its overreliance on the Florida market and lack of geographic diversity. Though the company reported strong earnings, its future growth potential is limited by increased competition and potential regulatory changes in key markets like Pennsylvania and Arizona. Additionally, its expansion into Texas and Alabama may not provide significant opportunities for growth compared to its other states.

TRLV has been analyzed by 1 analysts, with a consensus rating of Buy. 0% of analysts recommend a Strong Buy, 100% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Trulieve Cannabis Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Trulieve Cannabis Corp (TRLV) Forecast

Analysts have given TRLV a Buy based on their latest research and market trends.

According to 1 analysts, TRLV has a Buy consensus rating as of Sep 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $15, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $15, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Trulieve Cannabis Corp (TRLV)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.